IQVIA
IQV
#889
Rank
NZ$48.76 B
Marketcap
NZ$292.17
Share price
-1.70%
Change (1 day)
12.58%
Change (1 year)

Earnings for IQVIA (IQV)

Earnings in 2026 (TTM): NZ$4.02 Billion

According to IQVIA's latest financial reports the company's current earnings are NZ$16.63 Billion. In 2025 the company made an earning of NZ$4.04 Billion a decrease over its 2024 earnings that were of NZ$4.07 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for IQVIA from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$4.02 B-0.43%
2025 NZ$4.04 B-0.81%
2024 NZ$4.07 B9.76%
2023 NZ$3.71 B19.79%
2022 NZ$3.09 B18.36%
2021 NZ$2.61 B90.49%
2020 NZ$1.37 B-1.25%
2019 NZ$1.39 B7.68%
2018 NZ$1.29 B6.61%
2017 NZ$1.21 B11.74%
2016 NZ$1.08 B-2.79%
2015 NZ$1.11 B6.31%
2014 NZ$1.04 B34.96%
2013 NZ$0.77 B11.16%
2012 NZ$0.69 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-NZ$3.77 Million-100.09% Bahamas
NRC Health
NRC
NZ$48.01 M-98.83%๐Ÿ‡บ๐Ÿ‡ธ USA